Generic programmatic and clinical guide for the introduction of new drugs and shorter regimens for the treatment of Multi/Extensively Drug-Resistant TB

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.